Shuting Zhou
Shanghai, 200233, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling" [Biochem. Pharmacol. 250 (2026) 117995].
Journal: Biochemical pharmacology
Published: June 15, 2026
Corrigendum to "Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling" [Biochem. Pharmacol. 250 (Pt 1) (2026) 117995].
Journal: Biochemical pharmacology
Published: June 11, 2026
Activation of endothelial GABAA receptor α1 subunit protects against barrier dysfunction in acute lung injury.
Journal: BMC pulmonary medicine
Published: March 02, 2026
Descriptive oxidative and lipid-related fluorescence observations associated with Esketamine treatment in a high-concentration NMDA-exposed HT-22/C8-D1A co-culture model.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: February 14, 2026
Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling.
Journal: Biochemical pharmacology
Published: February 14, 2026
Epigenetic regulation of ACSL4 via H2A monoubiquitylation connects lipid metabolism to BAP1-mediated ferroptosis.
Journal: Cell death and differentiation
Published: June 20, 2025
Optimizing nitrogen removal in advanced wastewater treatment using biological aerated filters.
Journal: Frontiers in bioengineering and biotechnology
Published: July 12, 2024
Ursodeoxycholic acid alleviates fat embolism syndrome-induced acute lung injury by inhibiting the p38 MAPK/NF-κB signalling pathway through FXR.
Journal: Biochemical pharmacology
Published: April 10, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026